WiseGuyReports.Com Publish a New Market Research Report On –“ Aptamers 2019 Global Market Outlook,Research,Trends and Forecast to 2023”.
Aptamers Industry 2019
Aptamers market is growing at a significant CAGR owing to rise in the investment in biotechnology and pharmaceutical companies for R&D activities, technological developments, an increase in the therapeutic application anticipated to fuel the aptamers market over the forecast period. Furthermore, increase in the using of aptamers in drug discovery, entry of private organizations in research and development space, and advantages of aptamers over other therapeutics expected to drive the aptamers market. However, stringent regulatory policies and ethical issues in aptamers usage, dearth of aptamers in the market in the undeveloped regions, and lack of awareness about the aptamers usage expected to dampen the growth of aptamers market over the forecast period.
For more information or any query mail at firstname.lastname@example.org
Global Aptamers Market
Aptamers are the single-stranded peptide or oligonucleotide molecules that bind to the protein, nucleic acid molecules or target lipid with the high specificity. Aptamers are used in pharmaceutical studies, laboratory diagnosis, drug discovery, molecular recognition, and treatment of certain diseases. In addition, aptamers are also used in the production of cost-effective and improved medicines, the advantages of aptamers over protein therapeutics include in terms of synthetic accessibility, modification, and size. Aptamers are commonly used in the treatment of AIDS owing to faster development than the antibodies which lead to curing of diseases very faster.
Global aptamers market is segmented on the basis of aptamers type, application, and end user
Based on the aptamers type, Aptamers market is segmented into the following:
Nucleic acid aptamers
Based on the application, This market is segmented into the following
Research & Development
Based on the end user, This market is segmented into the following:
Research and academic institutes
Nowadays, Aptamers market is the growing stage with an increase in R&D activities by the various biopharmaceutical companies and research institutes. Technological advancements and drug innovations are expected to fuel the aptamers market. For instance, in 2014, MIT scientists created DNA-based drug targeting system comprising of aptamers and ultraviolet light which leads to binding of aptamers with high specificity. Acquisitions and mergers, collaborations, newer technologies launches, fundraising for aptamers development and patent approvals are some key strategies adopted by the companies to increase their share in the global aptamers market. For instance, in February 2012, Valent pharmaceutical acquired Eyetech and enters into the aptamers market with the marketing of Macugen anti-VEGF aptamers in U.S. Moreover, in February 2016, researchers from Institute of Bioengineering and Nanotechnology (Singapore) have developed more efficient DNA technology for detection and treatment of cancer and infectious diseases.
Geographically, Aptamers market is segmented into following regions, Viz. Europe, Latin America, North America, Asia Pacific, and the Middle East and Africa. North America is expected to hold a dominant share in aptamers market owing to technological advancements, a rise in collaboration of biopharmaceutical companies for R&D activities, and favourable government regulations for clinical trials. Europe has a significant growth in aptamers market owing to the adoption of developed aptamer technologies, increase in the prevalence of chronic diseases, an increase in the preference for aptamer-based treatment in Europe countries is the key factors expected to drive the aptamers market growth. Asia Pacific has shown lucrative growth over the forecast period owing to increase in the incidence and prevalence of chronic diseases, rise in demand for cost-effective treatment, increase in healthcare expenditure, and adoption of novel technologies majorly in Japan and China are the factors `expected to boost the aptamers market in the region.
Some of the players in Aptamers market are NeoVentures Biotechnology, Inc. (Canada), Aptagen, LLC (U.S.), Aptamer Solutions Ltd. (U.K.), SomaLogic, Inc. (U.S.), AM Biotechnologies, LLC (U.S.), TriLink BioTechnologies, Inc. (U.S.), Vivonics, Inc. (U.S.), and Apta Targets (Spain) to name a few.
Table Of Contents – Major Key Points
- Executive Summary
- Global Aptamers Market Introduction
- Global Aptamers Market Dynamics
- Global Aptamers Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023
- Global Aptamers Market, By Aptamer Type, 2012 – 2016 and Forecast, 2017 – 2023
- Global Aptamers Market Forecast, By Application, 2012 – 2016 and Forecast, 2017 – 2023
- Global Aptamers Market Forecast, By End-User, 2012 – 2016 and Forecast, 2017 – 2023
- Global Aptamers Market Forecast, By Region, 2012 – 2016 and Forecast, 2017 – 2023
- North America Aptamers Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023
- Europe Aptamers Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023
- Asia-Pacific Aptamers Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.